A., P; G., T; L., T; B., S; T., W; P., O; L., S; P., M; S., S; T., L; et al.
O-01: HYDROXYUREA REDUCES THE TRANSFUSION BURDEN IN CHILDREN WITH SICKLE CELL ANEMIA IN SUB-SAHARAN AFRICA: THE REACH EXPERIENCE.
HemaSphere.
2022;
6.
Abu Ata, N; Hammill, AM; Merrow, AC.
Neonatal vascular anomalies manifesting as soft-tissue masses.
Pediatric Radiology.
2022;
52:786-801.
Aukrust, CG; Parikh, K; Smart, LR; Mdala, I; Fjeld, HE; Lubuulwa, J; Makene, AM; Härtl, R; Winkler, AS.
Pediatric Hydrocephalus in Northwest Tanzania: A Descriptive Cross-Sectional Study of Clinical Characteristics and Early Surgical Outcomes from the Bugando Medical Centre.
World Neurosurgery.
2022;
161:e339-e346.
Berntorp, E; LeBeau, P; Ragni, MV; Borhany, M; Abajas, YL; Tarantino, MD; Holstein, K; Croteau, SE; Liesner, R; Tarango, C; et al.
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.
Haemophilia.
2022;
28:453-461.
Blei, F; Adams, D; Brandao, LR; Trenor, C; Iacobas, I; Hammill, A.
Forward: Welcome to the Special Issue on Vascular Anomalies.
Pediatric Blood and Cancer.
2022;
69 Suppl 3.
Boucher, AA; Francisco, BJ; Pfeiffer, A; Martin, M; Martin, J; Shova, A; Nathan, JD; Tiao, GM; Luchtman-Jones, L.
Urinary 11-dehydrothromboxane B2 aspirin efficacy testing is sensitive to perioperative inflammation in pediatric solid-organ transplant patients.
Pediatric Blood and Cancer.
2022;
69.
Cantrell, R; Palumbo, JS.
Hemostasis and tumor immunity.
Research and Practice in Thrombosis and Haemostasis.
2022;
6.
Filuta, A; Amezcua, PK; Chang, W; Biagini, J; Kroner, J; He, H; Grashel, B; Almasri, C; Martin, L; Palumbo, JS; et al.
LB1033 Thrombin contributes to atopic dermatitis pathogenesis and staphylococcus aureus skin colonization in children.
Journal of Investigative Dermatology.
2022;
142.
Forsyth, S; Schroeder, P; Geib, J; Vrishabhendra, L; Konstantinidis, DG; LaSalvia, K; Ribadeneira, MD; Wu, E; Kelly, P; Kalfa, TA.
Safety, Pharmacokinetics, and Pharmacodynamics of Etavopivat (FT-4202), an Allosteric Activator of Pyruvate Kinase-R, in Healthy Adults: A Randomized, Placebo-Controlled, Double-Blind, First-in-Human Phase 1 Trial.
Clinical Pharmacology in Drug Development.
2022;
11:654-665.
Goldenberg, NA; Kittelson, JM; Abshire, TC; Bonaca, M; Casella, JF; Dale, RA; Halperin, JL; Hamblin, F; Kessler, CM; Manco-Johnson, MJ; et al.
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
JAMA - Journal of the American Medical Association.
2022;
327:129-137.
Hood, AM; Crosby, LE; Hanson, E; Shook, LM; Lebensburger, JD; Madan-Swain, A; Miller, MM; Trost, Z.
The influence of perceived racial bias and health-related stigma on quality of life among children with sickle cell disease.
Ethnicity and Health.
2022;
27:833-846.
Hulbert, ML; Manwani, D; Meier, ER; Alvarez, OA; Brown, RC; Callaghan, MU; Campbell, AD; Coates, TD; Frei-Jones, MJ; Hankins, JS; et al.
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.
Pediatric Blood and Cancer.
2022.
Juang, LJ; Hur, WS; Silva, LM; Strilchuk, AW; Francisco, B; Leung, J; Robertson, MK; Groeneveld, DJ; La Prairie, B; Chun, EM; et al.
Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNA.
Blood.
2022;
139:1302-1311.
Kaj-Carbaidwala, B; Bernieh, A; Russi, AE; Miethke, AG; Abu-El-Haija, M; Trout, AT; Gupta, A; Ricci, KW; Nathan, JD.
Total pancreatectomy with islet autotransplantation in a child with pancreatic kaposiform hemangioendothelioma.
Journal of Pediatric Surgery Case Reports.
2022;
81.
Kumar, R; Dunn, AL; Schneiderman, JE; Gonzales, A; Bouskill, V; Widener, P; Stanek, J; Pluthero, FG; Waller, A; Tarango, C; et al.
Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial.
Blood.
2022;
140:1156-1166.
L., S; M., C; A., P; T., H; K., M; E., A; R., W.
O-12: BUILDING LOCAL CAPACITY FOR HYDROXYUREA PHARMACOKINETICS AND PRECISION DOSING IN LOW-RESOURCE SETTINGS.
HemaSphere.
2022;
6:07-08.
Lynch, DR; Stringham, EN; Zhang, B; Balbin-Cuesta, G; Curtis, BR; Palumbo, JS; Greineder, CF; Tourdot, BE.
Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies.
Blood Advances.
2022;
6:4645-4656.
M., T; R., B; R., H; M., I; I., O; T., K; F., K; J., G; P., S; E., WU; et al.
O-03: ETAVOPIVAT TREATMENT FOR UP TO 12 WEEKS IN PATIENTS WITH SICKLE CELL DISEASE IS WELL TOLERATED AND IMPROVES RED BLOOD CELL HEALTH.
HemaSphere.
2022;
6:02-03.
Macharia, AW; Mochamah, G; Makale, J; Howard, T; Mturi, N; Olupot-Olupot, P; Färnert, A; Ware, RE; Williams, TN.
Case Report: β-thalassemia major on the East African coast.
Wellcome Open Research.
2022;
7.
McGrady, ME; Todd, K; Ignjatovic, V; Jones, S; Rizzi, M; Luchtman-Jones, L; Thornburg, C.
Results of an international survey on adherence with anticoagulation in children, adolescents, and young adults: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.
Journal of Thrombosis and Haemostasis.
2022;
20:1720-1728.
Mwazyunga, Z; Ambrose, EE; Kayange, N; Bakalemwa, R; Kidenya, B; Smart, LR; Hokororo, A.
Health Related Quality of Life among Children with Sickle Cell Anaemia in Northwestern Tanzania.
2022;
12:11-28.
Nima, MK; Mukherjee, A; Sazed, SA; Hossainey, MR H; Phru, CS; Johora, FT; Safeukui, I; Saha, A; Khan, AA; Marma, AS P; et al.
Assessment of Plasmodium falciparum Artemisinin Resistance Independent of kelch13 Polymorphisms and with Escalating Malaria in Bangladesh.
mBio.
2022.
Niss, O; Quinn, CT.
Chapter 3 Classification and diagnosis of anemia in children and neonates.
Lanzkowsky's Manual of Pediatric Hematology and Oncology.
2022.
Noomuna, P; Hausman, JM; Sansoya, R; Kalfa, T; Risinger, M; Low, PS.
Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening.
FASEB Journal.
2022;
36.
O'Brien, SH; Badawy, SM; Rotz, SJ; Shah, MD; Makarski, J; Bercovitz, RS; Hogan, MJ S; Luchtman-Jones, L; Panepinto, JA; Priola, GM; et al.
The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question.
Blood Advances.
2022;
6:679-685.
Palumbo, J; Lensing, AW A; Brandão, LR; Hooimeijer, HL; Kenet, G; van Ommen, H; Pap, ÁF; Majumder, M; Kubitza, D; Thelen, K; et al.
Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr.
Blood Advances.
2022.
Palumbo, JS.
Crosstalk between hemostasis and immunity in cancer pathogenesis.
Thrombosis Research.
2022;
213 Suppl 1:S3-S7.
Power-Hays, A; Dandoy, CE; Lorts, A; Perentesis, JP; Unaka, N; Ware, RE; McGann, PT.
US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity.
Pediatric Blood and Cancer.
2022;
69.
Quinn, CT; Ware, RE.
Reproductive equity: preserve the reserve.
Blood.
2022;
139:963-965.
Quinn, CT; Ware, RE.
New therapeutics for children with sickle cell disease: A time for celebration, caution, or both?.
Pediatric Blood and Cancer.
2022;
69.
R., N; A., C; C., B; M., G; D., D; R., W; R., O; C., J.
PI-08: HIGH DISEASE BURDEN, MORBIDITY AND MORTALITY AMONG CHILDREN WITH SICKLE CELL ANAEMIA IN UGANDA.
HemaSphere.
2022;
6.
Real, FJ; Hood, AM; Davis, D; Cruse, B; Klein, M; Johnson, Y; McTate, E; Brinkman, WB; Hackworth, R; Hackworth, K; et al.
An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia.
Journal of Pediatric Hematology/Oncology.
2022;
44:e799-e803.
Ricci, KW; Iacobas, I.
How we approach the diagnosis and management of complex lymphatic anomalies.
Pediatric Blood and Cancer.
2022;
69 Suppl 3.
Sabulski, A; Nehus, EJ; Jodele, S; Ricci, K.
Diagnostic Considerations in H1N1 Influenza-induced Thrombotic Microangiopathy.
Journal of Pediatric Hematology/Oncology.
2022;
44:e237-e240.
Sadler, B; Minard, CG; Haller, G; Gurnett, CA; O'Brien, SH; Wheeler, A; Jain, S; Sharma, M; Zia, A; Kulkarni, R; et al.
Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations.
Blood Advances.
2022;
6:420-428.
Schroeder, P; Fulzele, K; Forsyth, S; Ribadeneira, MD; Guichard, S; Wilker, E; Marshall, CG; Drake, A; Fessler, R; Konstantinidis, DG; et al.
Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
Journal of Pharmacology and Experimental Therapeutics.
2022;
380:210-219.
Setty, BA; Wusik, K; Hammill, AM.
How we approach genetics in the diagnosis and management of vascular anomalies.
Pediatric Blood and Cancer.
2022;
69 Suppl 3.
Shook, LM; Farrell, CB; Mosley, C.
Expanding a Regional Sickle Cell Disease Project ECHO® to Rapidly Disseminate COVID-19 Education.
Advances in Medical Education and Practice.
2022;
13:443-447.
Smart, LR; Ambrose, EE; Balyorugulu, G; Songoro, P; Shabani, I; Komba, P; Charles, M; Howard, TA; McElhinney, KE; O'Hara, SM; et al.
Stroke Prevention with Hydroxyurea Enabled through Research and Education (SPHERE): a Phase 2 primary stroke prevention trial in sub-Saharan Africa.
Acta Haematologica.
2022.
T., C; A., LA L; R., B; T., K; J., K; J., B; C., T; K., W; S., S.
P-055: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE ERYTHROCYTE PYRUVATE KINASE ACTIVATOR ETAVOPIVAT IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE.
HemaSphere.
2022;
6:43-44.
Todd, KE; McGrady, ME; Starbuck, E; Previtera, M; Luchtman-Jones, L.
A systematic review of adherence to anticoagulation regimens in pediatric patients.
Pediatric Blood and Cancer.
2022;
69.
Tseng, SY; Gao, Z; Kalfa, TA; Ollberding, NJ; Tabbah, S; Keller, R; Cnota, JF.
Altered erythropoiesis in newborns with congenital heart disease.
Pediatric Research.
2022;
91:606-611.
Tu, Z; Fan, C; Davis, AK; Hu, M; Wang, C; Dandamudi, A; Seu, KG; Kalfa, TA; Lu, QR; Zheng, Y.
Autism-associated chromatin remodeler CHD8 regulates erythroblast cytokinesis and fine-tunes the balance of Rho GTPase signaling.
Cell Reports.
2022;
40.
Wagner, ML; Johnston, M; Jenkins, T; Palumbo, JS; Rymeski, BA.
Use of thromboelastography in children on extracorporeal membrane oxygenation.
Journal of Pediatric Surgery.
2022;
57:1056-1061.